文献速递慢阻肺呼吸道感染

慢性阻塞性肺疾病巨噬细胞线粒体杀菌反应受损

Impaired Mitochondrial Microbicidal Responses in Chronic Obstructive Pulmonary Disease Macrophages.
PubMed 文献 · Am J Respir Crit Care Med · 2017-01-01

本研究探讨慢阻肺患者肺泡巨噬细胞对肺炎链球菌的杀菌反应,发现患者巨噬细胞Mcl-1升高且延迟胞内杀菌选择性减弱,转基因小鼠模型重现该缺陷,机制涉及线粒体活性氧产生受损及mROS/SOD2比值降低。

要点

  • 慢阻肺肺泡巨噬细胞Mcl-1升高,延迟胞内杀菌选择性减弱。
  • 巨噬细胞Mcl-1转基因小鼠肺细菌清除受损、中性粒细胞炎症增加。
  • 慢阻肺巨噬细胞基础mROS升高但肺炎链球菌攻击后不能增加mROS。

核心结论

  • Mcl-1上调及对氧化应激的慢性适应改变线粒体代谢和杀菌功能,削弱慢阻肺延迟期胞内细菌清除。

研究设计与样本

  • 获取健康供者或慢阻肺患者支气管肺泡灌洗液中的肺泡巨噬细胞,用调理的血清型14肺炎链球菌攻击。
  • 检测细胞凋亡、杀菌活性和线粒体活性氧产生。
  • 使用CD68启动子确保巨噬细胞特异性表达人Mcl-1的转基因小鼠模型模拟慢阻肺分子特征。

主要发现

  • 慢阻肺肺泡巨噬细胞Mcl-1升高,延迟胞内杀菌选择性减弱。
  • CD68.hMcl-1转基因小鼠肺细菌清除受损、中性粒细胞炎症增加,重现杀菌缺陷。
  • 小鼠骨髓来源巨噬细胞和人单核来源巨噬细胞产生mROS并与细菌及吞噬溶酶体共定位以增强杀菌。
  • Mcl-1转基因增加模拟感染骨髓来源巨噬细胞的耗氧率和mROS表达,但减少肺炎链球菌攻击后caspase依赖性mROS产生。
  • 慢阻肺肺泡巨噬细胞基础mROS增加,但攻击后不能增加产生,且胞内杀菌缺陷与mROS/超氧化物歧化酶2比值降低相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Chronic obstructive pulmonary disease (COPD) is characterized by impaired clearance of pulmonary bacteria. OBJECTIVES: The effect of COPD on alveolar macrophage (AM) microbicidal responses was investigated. METHODS: AMs were obtained from bronchoalveolar lavage from healthy donors or patients with COPD and challenged with opsonized serotype 14 Streptococcus pneumoniae. Cells were assessed for apoptosis, bactericidal activity, and mitochondrial reactive oxygen species (mROS) production. A transgenic mouse line in which the CD68 promoter ensures macrophage-specific expression of human induced myeloid leukemia cell differentiation protein Mcl-1 (CD68.hMcl-1) was used to model the molecular aspects of COPD. MEASUREMENTS AND MAIN RESULTS: COPD AMs had elevated levels of Mcl-1, an antiapoptotic B-cell lymphoma 2 family member, with selective reduction of delayed intracellular bacterial killing. CD68.hMcl-1 AMs phenocopied the microbicidal defect because transgenic mice demonstrated impaired clearance of pulmonary bacteria and increased neutrophilic inflammation. Murine bone marrow-derived macrophages and human monocyte-derived macrophages generated mROS in response to pneumococci, which colocalized with bacteria and phagolysosomes to enhance bacterial killing. The Mcl-1 transgene increased oxygen consumption rates and mROS expression in mock-infected bone marrow-derived macrophages but reduced caspase-dependent mROS production after pneumococcal challenge. COPD AMs also increased basal mROS expression, but they failed to increase production after pneumococcal challenge, in keeping with reduced intracellular bacterial killing. The defect in COPD AM intracellular killing was associated with a reduced ratio of mROS/superoxide dismutase 2. CONCLUSIONS: Up-regulation of Mcl-1 and chronic adaption to oxidative stress alter mitochondrial metabolism and microbicidal function, reducing the delayed phase of intracellular bacterial clearance in COPD.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Bewley MA, Preston JA, Mohasin M, et al. Impaired Mitochondrial Microbicidal Responses in Chronic Obstructive Pulmonary Disease Macrophages. Am J Respir Crit Care Med. 2017. PMID: 28557543. doi:10.1164/rccm.201608-1714OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。